|1.||Gonzàlez-Duarte, Roser: 3 articles (01/2014 - 01/2004)|
|2.||Mitsutake, Susumu: 3 articles (05/2012 - 05/2006)|
|3.||Igarashi, Yasuyuki: 3 articles (05/2012 - 05/2006)|
|4.||Gao, Meng: 2 articles (11/2015 - 07/2014)|
|5.||Chen, Jiaxiang: 2 articles (11/2015 - 07/2014)|
|6.||Wang, Jiuxiang: 2 articles (11/2015 - 07/2014)|
|7.||Li, Chang: 2 articles (11/2015 - 07/2014)|
|8.||Liu, Fei: 2 articles (11/2015 - 07/2014)|
|9.||Liu, Ying: 2 articles (11/2015 - 07/2014)|
|10.||Tang, Zhaohui: 2 articles (11/2015 - 07/2014)|
|2.||Retinitis Pigmentosa (Pigmentary Retinopathy)
01/01/2014 - "The function of CERKL (CERamide Kinase Like), a causative gene of retinitis pigmentosa and cone-rod dystrophy, still awaits characterization. "
05/01/2013 - "Mutations in Ceramide Kinase-Like (CERKL) cause autosomal recessive Retinitis Pigmentosa and Cone Rod Dystrophy. "
01/01/2013 - "Mutations in the Ceramide kinase like (CERKL) gene are associated with retinitis pigmentosa (RP26) and cone-rod dystrophy. "
05/12/2006 - "A mutation in a new ceramide kinase (CERK) homologous gene, named CERK-like protein (CERKL), was found to cause autosomal recessive retinitis pigmentosa (RP26). "
01/01/2004 - "Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)."
11/01/2014 - "Ceramide kinase promotes tumor cell survival and mammary tumor recurrence."
11/01/2014 - "We now report that ceramide kinase (Cerk) is required for mammary tumor recurrence following HER2/neu pathway inhibition and is spontaneously upregulated during tumor recurrence in multiple genetically engineered mouse models for breast cancer. "
08/01/2009 - "Differences in expression of ceramide galactosyl transferase (UGT8), ceramide kinase (CERK), and Ganglioside GD3-Synthase (ST8SIA1) in breast cancer cells were investigated by using microarray data of 1,581 tumor samples. "
05/01/2012 - "The effects of enzyme inhibitors of sphingomyelin synthase, ceramide kinase and glucosylceramide synthase on cancer cell proliferation, sensitivity to chemotherapeutics, induction of apoptosis or growth of xenografts are presented."
08/22/2013 - "C1P produced by ceramide kinase is an activator of group IVA cytosolic phospholipase A2α (cPLA2α), the rate-limiting releaser of arachidonic acid used for pro-inflammatory eicosanoid production, which contributes to disease pathogenesis in asthma or airway hyper-responsiveness, cancer, atherosclerosis and thrombosis. "
01/01/2014 - "Ceramide kinase (CerK) catalyzes the generation of the sphingolipid ceramide-1-phosphate (C1P) which regulates various cellular functions including cell growth and death, and inflammation. "
01/01/2012 - "Ceramide kinase (CERK) has been implicated in important cellular processes such as inflammation and apoptosis. "
08/01/2011 - "Ceramide-1-phosphate (C1P), produced by ceramide kinase (CERK), is implicated in the regulation of many biological functions including cell growth and inflammation. "
06/01/2013 - "The present review highlights novel aspects on the regulation of inflammation by sphingolipids, with special emphasis to the role played by ceramide 1-phosphate and ceramide kinase, the enzyme responsible for its biosynthesis, in inflammatory responses."
|2.||Interleukin-4 (Interleukin 4)
|3.||Immunoglobulin E (IgE)
|5.||Nuclear Localization Signals (Nuclear Localization Signal)
|6.||NADPH Oxidase (NAD(P)H oxidase)
|7.||Arachidonic Acid (Vitamin F)
|1.||Heterologous Transplantation (Xenotransplantation)